Web Stats Provided By Google Analytics

Thursday, January 23, 2014

BioLineRx Receives Orphan Drug Designation for Novel Stem Cell Mobilization Treatment

Orphan Drug Designation is granted to therapeutics intended to treat rare diseases that affect not more than 200,000 people in .

http://ift.tt/KMgh8q
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Healthcare Law Roundup Posts